Concepedia

Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease

Alain Lescoat, M Lelong, Mohamed Jeljeli, Claire Piquet‐Pellorce, Claudie Morzadec, Alice Ballerie, S. Jouneau, Patrick Jégo, Laurent Vernhet, Frédéric Batteux,

Biochemical Pharmacology · 2020 · 185 citations · 48 references

DOI

Concepts

References

48

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

Oliver Distler, Kristin B. Highland, Martina Gahlemann et al. · New England Journal of Medicine · 2019 · 1.6K citations · Full text

, , +13

Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients

Yong Xiong, Yuan Liu, Liu Cao et al. · Emerging Microbes & Infections · 2020 · 1.2K citations · Full text

, , +17

Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis

Srđan Verstovšek, Hagop M. Kantarjian, Ruben A. Mesa et al. · New England Journal of Medicine · 2010 · 1.2K citations · Full text

, , +13

Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span

Alexander V. Misharin, Luisa Morales‐Nebreda, Paul A. Reyfman et al. · The Journal of Experimental Medicine · 2017 · 1.1K citations · Full text

, , +17

Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis

Roy Fleischmann, Joel M. Kremer, John J. Cush et al. · New England Journal of Medicine · 2012 · 1K citations · Full text

, , +12